Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H23NO4 |
| Molecular Weight | 365.4223 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=CC2=C(NC=C(C(=O)OC)C2=O)C=C1OCC3=CC=CC=C3
InChI
InChIKey=NNOPDLNHPOLRRE-UHFFFAOYSA-N
InChI=1S/C22H23NO4/c1-3-4-10-16-11-17-19(23-13-18(21(17)24)22(25)26-2)12-20(16)27-14-15-8-6-5-7-9-15/h5-9,11-13H,3-4,10,14H2,1-2H3,(H,23,24)
| Molecular Formula | C22H23NO4 |
| Molecular Weight | 365.4223 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL612854 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Statyl Approved UseAn aid in the prevention of coccidiosis caused by E. tenella, E. necatrix, E. acervulina, E. maxima, E. brunetti, and E. mivati. in poultry. |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 15.0 |
no |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 18.0 |
no |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.law.cornell.edu/cfr/text/21/558.365
Chickens: Amount per ton. Nequinate, 18.16 grams (0.002 percent). Feed continuously as the sole ration; do not feed to chickens over 16 weeks of age.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1070675
Curator's Comment: Chick kidney cell cultures and sporozoites of a Japanese (Azabu) strain of
Eimeria tenella were used. Samples of methyl benzoquate, which did not dissolve in this mixture, were mechanically shaken in it
with glass beads to effect dispersion. These stock formulations
were further diluted with culture medium to x 10 required final concentration.
Semi-confluent monolayers were inoculated with 150000 sporozoites in 1-8 ml
medium containing 2-5 % foetal calf serum. The drug was added as 0-2 ml per well of the x 10 concentrated suspension.
M.E.D. (minimum effective dose) = 0.001 ppm
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:53:25 GMT 2025
by
admin
on
Mon Mar 31 17:53:25 GMT 2025
|
| Record UNII |
91ZE013933
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 558.365
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
||
|
CFR |
21 CFR 556.440
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB09202MIG
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
100000084156
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
26383
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
m7826
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
13997-19-8
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
DB11433
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
2591
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
DTXSID2048610
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
C76424
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
C057040
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
91ZE013933
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
237-796-6
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104807
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |